Que Veut Dire DOCUMENT IS AUTHORISED en Français - Traduction En Français

• document is authorised

Exemples d'utilisation de Document is authorised en Danois et leurs traductions en Français

EMEA 2006 Reproduction and/ or distribution of this document is authorised for non- commercial purposes only provided the EMEA is acknowledged Indhold Indledning ved eksekutivdirektøren.
EMEA 2006 Reproduction and/ or distribution of this document is authorised for non-commercial purposes only provided the EMEA is acknowledged Table des matières Introduction du directeur exécutif.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged og af TORISEL,?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quelles études ont été menées avec TORISEL?

EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged. med placebo(en uvirksom behandling) med hensyn til vægttab over et til to år.
EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged. celui d'un placebo(un traitement fictif) sur la perte de poids sur une période d'un à deux ans.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@ emea. eu. int http:// www. emea. eu. int© EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged* Bemærkninger.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@emea. eu. int http:/ /www. emea. eu. int© EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged* Remarques.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@ emea. eu. int http:// www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Cefovecin afviger fra andre lignende cefalosporin- antibiotika, da det forbliver i hunden eller kattens krop i meget lang tid efter, at det er blevet indsprøjtet.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@emea. eu. int http:/ /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged La céfovécine diffère des autres céphalosporines similaires car elle reste présente dans l'organisme du chien ou du chat pendant une longue période après l'injection.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@ emea. eu. int http:// www. emea. eu. int EMEA 2004 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged* Bemærkninger.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@emea. eu. int http:/ /www. emea. eu. int EMEA 2004 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged La liste des dénominations concernées est fournie en annexe I.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 13 E- mail: mail@ emea. eu. int http:// www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Den endelige udtalelse blev konverteret til en afgørelse truffet af Europa- Kommissionen den 21. februar 2006.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 13 E- mail: mail@emea. eu. int http:/ /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged L'avis définitif est devenu décision de la Commission européenne en date du 21 février 2006.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilken fordel viser undersøgelserne.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged andelen af patienter, for hvem behandlingen ikke havde virket(tegn på moderat eller svær betændelse i øjet).
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged proportion de patients dont le traitement avait échoué(avec des signes d'inflammation modérée ou grave de l'œ il).

(44- 20) 74 18 84 00 Fax(44- 20) 75 23 71 29 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged giver sin mening til kende.
(44- 20) 74 18 84 00 Fax(44- 20) 75 23 71 29 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Habituellement.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. eu. int http:// www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Virkningen af Baraclude ved kronisk hepatitis B er blevet sammenlignet med virkningen af lamivudin i tre kliniske hovedundersøgelser.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@emea. eu. int http:/ /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged L'efficacité de Baraclude pour le traitement de l'hépatite B chronique a été comparée à celle de la lamivudine au cours de 3 principales études cliniques.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvordan blev ProMeris undersøgt?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Comment ProMeris a- t- il été étudié?

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Der er blevet gennemført feltundersøgelser hos hunde på dyrlægeklinikker i en række europæiske lande og i forskellige geografiske områder.
( 44- 20) 74 18 84 00 Fax( 44- 20) 74 18 84 47 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Deux études sur le terrain ont été menées sur des chiens, dans des cabinets vétérinaires de plusieurs pays européens et dans différentes régions géographiques.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvordan blev Aldurazyme undersøgt?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quelles études ont été menées avec Aldurazyme?

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@ emea. eu. int http:// www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvordan er virkningen af Zubrin undersøgt?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@emea. eu. int http:/ /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Comment l'efficacité de Zubrin a- t- elle été étudiée?

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilke bivirkninger har Meloxivet?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quel est le risque associé à l'utilisation de Meloxivet?

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilken fordel viser undersøgelserne, at der er ved Actrapid?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quelles études ont été menées avec Actrapid?

(44- 20) 74 18 84 00 Fax(44- 20) 75 23 71 29 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged referencelægemiddel med hensyn til sikkerhed og virkning.
(44 - 20) 74 18 84 00 Fax(44 - 20) 75 23 71 29 E-mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged référence en termes de sécurité ou d'efficacité.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilken fordel viser undersøgelserne, at der er ved SevoFlo?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quel est le bénéfice démontré par SevoFlo au cours des études?

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Focetria indeholder små mængder af viruset H5N1.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Focetria contient de petites quantités de fragments d'un virus appelé H5N1.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilken fordel viser undersøgelserne, at der er ved Kentera?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quels ont été les bénéfices démontrés par Kentera au cours des études?

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. eu. int ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged ikke længere havde nogen virkning.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged cadre d'une étude principale portant sur 903 patients, chez qui un traitement anti- cancéreux avait cessé ses effets.

(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilken fordel viser undersøgelserne.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@emea. europa. eu http:/ /www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged contenant trois principes actifs similaires chez les chiens atteints d'infections bactériennes ou fongiques aiguës ou répétées.